OREANDA-NEWS. Chimpharm JSC (Shymkent, hereinafter – the Company), whose securities are officially listed on Kazakhstan Stock Exchange (KASE), has by an official letter informed KASE that "the Board of Directors of Chimpharm JSC decided to buy 8,900 registered coupon bonds of Chimpharm JSC NIN KZ2C0Y05E370 from holder Visor Capital JSC for the acquisition price of KZT1,019.8 (one thousand nineteen tenge and eighty tiyn) with a coupon payout on the day of the transaction.".